About the Company
at twist bioscience, our expertise is synthetic dna. we have developed a proprietary semiconductor-based synthetic dna manufacturing process featuring a 10,000-well silicon platform capable of producing synthetic biology tools, such as oligonucleotides, genes, pathways, chassis and genomes. by synthesizing dna on silicon instead of on traditional 96-well plastic plates, our platform overcomes the current inefficiencies of synthetic dna production, and enables cost-effective, rapid, high-quality and high throughput synthetic gene production. the twist bioscience platform has the potential to greatly accelerate the development of personalized medicine, sustainable chemical production, improved agriculture production as well as new applications such as in vivo diagnostics, biodetection and data storage. for more information, please visit www.twistbioscience.com .
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
Employees
1038
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $TWST News
Twist Bioscience Launches IVDR-compliant Precision Dx Products for Whole Exome Sequencing
March 05, 2024--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through ...
Twist Bioscience Corp TWST
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Why Is DNA Synthesis Company Twist Bioscience Stock Trading Higher Today?
Twist Bioscience Corp (NASDAQ:TWST) shares are trading higher after the company released first-quarter 2024 earnings and increased its FY24 revenue guidance. The DNA synthesis company reported ...
Twist Bioscience and Element Biosciences Collaborate on Exome Sequencing Solutions for AVITI System
Twist for Element, Exome 2.0 plus Comprehensive Exome Spike-in Workflow expected to be available soon Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its ...
Twist Bioscience Launches cfDNA Library Preparation Kit for Liquid Biopsy Applications
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its ...
Q1 2024 Twist Bioscience Corp Earnings Call
Q1 2024 Twist Bioscience Corp Earnings Call Q1 2024 Twist Bioscience Corp Earnings Call INICIO CORREO NOTICIAS FINANZAS DEPORTES CELEBRIDADES VIDA Y ESTILO MÁS... Yahoo Finanzas Iniciar sesión Correo ...
Twist Bioscience Corp.
Twist Bioscience Corp. engages in the development of a proprietary semiconductor-based synthetic DNA manufacturing process. It operates through the following geographical segments: Americas ...
Twist Bioscience Launches IVDR-compliant Precision Dx Products for Whole Exome Sequencing
Twist Precision Exome Dx Panel and Twist Precision Exome Dx Kit Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA ...
Twist Bioscience Corp (0ME)
Investing.com - Twist Bioscience (NASDAQ: TWST) reported fourth quarter EPS of $-0.81, $0.11 better than the analyst estimate of $-0.92. Revenue for the quarter came in at $66.9M ...
Twist Bioscience Corp TWST
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Twist Bioscience Corp (TWST)
July was an excellent month for global stock markets Historically, the S&P 500 takes about 19 months to recover from a bear market However, since 1982, if the bear market does ...
Loading the latest forecasts...